Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Equity IncomeIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & Administrative
Others
Ratios

Addex Therapeutics (ADXN) Non Operating Income (2022 - 2024)

Historic Non Operating Income for Addex Therapeutics (ADXN) over the last 4 years, with Q3 2025 value amounting to -$1021.3.

  • Addex Therapeutics' Non Operating Income rose 9709.31% to -$1021.3 in Q3 2025 from the same period last year, while for Sep 2025 it was $15851.6, marking a year-over-year increase of 10539.61%. This contributed to the annual value of $26198.7 for FY2024, which is 10914.88% up from last year.
  • As of Q3 2025, Addex Therapeutics' Non Operating Income stood at -$1021.3, which was up 9709.31% from $7043.2 recorded in Q2 2025.
  • In the past 5 years, Addex Therapeutics' Non Operating Income registered a high of $61440.9 during Q3 2022, and its lowest value of -$294798.2 during Q4 2022.
  • Its 4-year average for Non Operating Income is -$53978.2, with a median of -$21299.6 in 2025.
  • Data for Addex Therapeutics' Non Operating Income shows a peak YoY increase of 248298.83% (in 2024) and a maximum YoY decrease of 18060.1% (in 2024) over the last 5 years.
  • Over the past 4 years, Addex Therapeutics' Non Operating Income (Quarter) stood at -$294798.2 in 2022, then increased by 1.72% to -$289730.1 in 2023, then surged by 110.74% to $31129.3 in 2024, then crashed by 103.28% to -$1021.3 in 2025.
  • Its Non Operating Income stands at -$1021.3 for Q3 2025, versus $7043.2 for Q2 2025 and -$21299.6 for Q1 2025.